BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 20142249)

  • 21. Identification of Catalposide Metabolites in Human Liver and Intestinal Preparations and Characterization of the Relevant Sulfotransferase, UDP-glucuronosyltransferase, and Carboxylesterase Enzymes.
    Hwang DK; Kim JH; Shin Y; Choi WG; Kim S; Cho YY; Lee JY; Kang HC; Lee HS
    Pharmaceutics; 2019 Jul; 11(7):. PubMed ID: 31336576
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gilbert's disease and atazanavir: from phenotype to UDP-glucuronosyltransferase haplotype.
    Lankisch TO; Moebius U; Wehmeier M; Behrens G; Manns MP; Schmidt RE; Strassburg CP
    Hepatology; 2006 Nov; 44(5):1324-32. PubMed ID: 17058217
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Polymorphisms in the estrogen receptor alpha gene (ESR1), daily cycling estrogen and mammographic density phenotypes.
    Fjeldheim FN; Frydenberg H; Flote VG; McTiernan A; Furberg AS; Ellison PT; Barrett ES; Wilsgaard T; Jasienska G; Ursin G; Wist EA; Thune I
    BMC Cancer; 2016 Oct; 16(1):776. PubMed ID: 27717337
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Association of polymorphisms in SULT1A1 and UGT1A1 Genes with breast cancer risk and phenotypes in Russian women].
    Shatalova EG; Loginov VI; Braga EA; Kazubskaia TP; Sudomoina MA; Blanchard RL; Favorova OO
    Mol Biol (Mosk); 2006; 40(2):263-70. PubMed ID: 16637266
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Contribution of the different UDP-glucuronosyltransferase (UGT) isoforms to buprenorphine and norbuprenorphine metabolism and relationship with the main UGT polymorphisms in a bank of human liver microsomes.
    Rouguieg K; Picard N; Sauvage FL; Gaulier JM; Marquet P
    Drug Metab Dispos; 2010 Jan; 38(1):40-5. PubMed ID: 19841060
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gilbert syndrome redefined: a complex genetic haplotype influences the regulation of glucuronidation.
    Ehmer U; Kalthoff S; Fakundiny B; Pabst B; Freiberg N; Naumann R; Manns MP; Strassburg CP
    Hepatology; 2012 Jun; 55(6):1912-21. PubMed ID: 22213127
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effect of UGT1A and UGT2B polymorphisms on colorectal cancer risk: haplotype associations and gene–environment interactions.
    Angstadt AY; Hartman TJ; Lesko SM; Muscat JE; Zhu J; Gallagher CJ; Lazarus P
    Genes Chromosomes Cancer; 2014 Jun; 53(6):454-66. PubMed ID: 24822274
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Quantitative analysis of UDP-glucuronosyltransferase (UGT) 1A and UGT2B expression levels in human livers.
    Izukawa T; Nakajima M; Fujiwara R; Yamanaka H; Fukami T; Takamiya M; Aoki Y; Ikushiro S; Sakaki T; Yokoi T
    Drug Metab Dispos; 2009 Aug; 37(8):1759-68. PubMed ID: 19439486
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cancer and molecular biomarkers of phase 2.
    Dalhoff K; Buus Jensen K; Enghusen Poulsen H
    Methods Enzymol; 2005; 400():618-27. PubMed ID: 16399374
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Phase II metabolism of betulin by rat and human UDP-glucuronosyltransferases and sulfotransferases.
    Hu Z; Wang Z; Luo S; James MO; Wang Y
    Chem Biol Interact; 2019 Apr; 302():190-195. PubMed ID: 30776358
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Phase II metabolism of hesperetin by individual UDP-glucuronosyltransferases and sulfotransferases and rat and human tissue samples.
    Brand W; Boersma MG; Bik H; Hoek-van den Hil EF; Vervoort J; Barron D; Meinl W; Glatt H; Williamson G; van Bladeren PJ; Rietjens IM
    Drug Metab Dispos; 2010 Apr; 38(4):617-25. PubMed ID: 20056724
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Preclinical discovery of candidate genes to guide pharmacogenetics during phase I development: the example of the novel anticancer agent ABT-751.
    Innocenti F; Ramírez J; Obel J; Xiong J; Mirkov S; Chiu YL; Katz DA; Carr RA; Zhang W; Das S; Adjei A; Moyer AM; Chen PX; Krivoshik A; Medina D; Gordon GB; Ratain MJ; Sahelijo L; Weinshilboum RM; Fleming GF; Bhathena A
    Pharmacogenet Genomics; 2013 Jul; 23(7):374-81. PubMed ID: 23670235
    [TBL] [Abstract][Full Text] [Related]  

  • 33. UDP-glucuronosyltransferase (UGT) polymorphisms affect atorvastatin lactonization in vitro and in vivo.
    Riedmaier S; Klein K; Hofmann U; Keskitalo JE; Neuvonen PJ; Schwab M; Niemi M; Zanger UM
    Clin Pharmacol Ther; 2010 Jan; 87(1):65-73. PubMed ID: 19794410
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [In vitro characterization of glucuronosyl- and sulfotransferases involved in the conjugation of ethanol].
    Stachel N; Skopp G
    Arch Kriminol; 2015; 235(1-2):29-42. PubMed ID: 26419090
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sulfation of fulvestrant by human liver cytosols and recombinant SULT1A1 and SULT1E1.
    Edavana VK; Yu X; Dhakal IB; Williams S; Ning B; Cook IT; Caldwell D; Falany CN; Kadlubar S
    Pharmgenomics Pers Med; 2011 Nov; 4():137-145. PubMed ID: 22822301
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Glucuronidation of OTS167 in Humans Is Catalyzed by UDP-Glucuronosyltransferases UGT1A1, UGT1A3, UGT1A8, and UGT1A10.
    Ramírez J; Mirkov S; House LK; Ratain MJ
    Drug Metab Dispos; 2015 Jul; 43(7):928-35. PubMed ID: 25870101
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adolescent intake of animal fat and red meat in relation to premenopausal mammographic density.
    Bertrand KA; Burian RA; Eliassen AH; Willett WC; Tamimi RM
    Breast Cancer Res Treat; 2016 Jan; 155(2):385-93. PubMed ID: 26791521
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association of genetic polymorphisms in UGT1A1 with breast cancer and plasma hormone levels.
    Guillemette C; De Vivo I; Hankinson SE; Haiman CA; Spiegelman D; Housman DE; Hunter DJ
    Cancer Epidemiol Biomarkers Prev; 2001 Jun; 10(6):711-4. PubMed ID: 11401924
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cyclic endogenous estrogen and progesterone vary by mammographic density phenotypes in premenopausal women.
    Iversen A; Frydenberg H; Furberg AS; Flote VG; Finstad SE; McTiernan A; Ursin G; Wilsgaard T; Ellison PT; Jasienska G; Thune I
    Eur J Cancer Prev; 2016 Jan; 25(1):9-18. PubMed ID: 25714648
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mammographic density change in a cohort of premenopausal women receiving tamoxifen for breast cancer prevention over 5 years.
    Brentnall AR; Warren R; Harkness EF; Astley SM; Wiseman J; Fox J; Fox L; Eriksson M; Hall P; Cuzick J; Evans DG; Howell A
    Breast Cancer Res; 2020 Sep; 22(1):101. PubMed ID: 32993747
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.